前收市價 | 38.71 |
開市 | 38.75 |
買盤 | 38.90 x 100 |
賣出價 | 38.97 x 100 |
今日波幅 | 38.75 - 39.42 |
52 週波幅 | 29.85 - 45.00 |
成交量 | |
平均成交量 | 1,041,800 |
市值 | 4.951B |
Beta 值 (5 年,每月) | 1.25 |
市盈率 (最近 12 個月) | 18.56 |
每股盈利 (最近 12 個月) | 2.10 |
業績公佈日 | 2024年5月07日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 51.11 |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Halozyme Therapeutics (HALO) could produce exceptional returns because of its solid growth attributes.
Halozyme Therapeutics (HALO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.